CASI logo

CASI Pharmaceuticals (CASI) Revenue

Annual Revenue

$33.88 M
-$9.23 M-21.41%

December 31, 2023

Summary

Performance

1-Year Change

-21.41%

3-Year Change

+123.76%

5-Year Change

-

15-Year Change

-

CASI Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

42.9%
CASI annual revenue is higher than 42.9% of companies in Healthcare sector

Analysts Estimate

$19.80 M
CASI annual revenue is currently +71.15% higher than the consensus analysts' forecast

High & Low

All-time High

$43.11 M
CASI annual revenue is currently -21.41% below its historical high of $43.11 million

3-Year Low

$30.17 M
CASI annual revenue is currently +12.30% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CASI previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 28, 2025
CASI next annual earnings announcement is scheduled for Mar 28, 2025

OtherCASIprofitabilitymetrics:

Annual EPS

-$2.02
CASI annual earnings per share is -$2.02

Annual Net Income

-$26.94 M
CASI annual net profit is -$26.94 million

Annual Operating Profit

-$25.28 M
CASI annual operating income is -$25.28 million

Annual Gross Profit

$20.05 M
CASI annual gross profit is $20.05 million

Quarterly Revenue

$7.79 M
+$3.81 M+95.85%

September 1, 2024

Summary

Performance

3-Month Change

+95.85%

1-Year Change

+13.37%

3-Year Change

+13.37%

5-Year Change

+13.37%

CASI Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.74%
CASI quarterly revenue is higher than 37.74% of companies in Healthcare sector

Analysts Estimate

$7.39 M
CASI quarterly revenue is currently +5.40% higher than the consensus analysts' forecast

High & Low

All-time High

$15.26 M
CASI quarterly revenue is currently -48.93% below its historical high of $15.26 million

3-Year Low

$3.41 M
CASI quarterly revenue is currently +128.60% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CASI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
CASI next earnings announcement is scheduled for Mar 28, 2025

Related metrics

Quarterly Gross Profit

$4.04 M
CASI quarterly gross profit is $4.04 million

Quarterly Operating Profit

-$8.09 M
CASI quarterly operating income is -$8.09 million

Quarterly Net Income

-$8.39 M
CASI quarterly net profit is -$8.39 million

Quarterly EPS

-$0.55
CASI quarterly earnings per share is -$0.55

TTM Revenue

$22.05 M
-$1.04 M-4.52%

September 1, 2024

Summary

Performance

3-Month Change

-4.52%

1-Year Change

-34.9%

3-Year Change

-34.9%

5-Year Change

-34.9%

CASI TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

34.09%
CASI TTM revenue is higher than 34.09% of companies in Healthcare sector

Analysts Estimate

$22.57 M
CASI TTM revenue is currently -2.30% lower than the consensus analysts' forecast

High & Low

All-time High

$43.64 M
CASI TTM revenue is currently -49.46% below its historical high of $43.64 million

3-Year Low

$22.05 M
CASI TTM revenue is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CASI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
CASI next earnings announcement is scheduled for Mar 28, 2025

OtherCASIprofitabilitymetrics:

TTM Gross Profit

$11.98 M
CASI TTM gross profit is $11.98 million

TTM Operating Profit

-$31.62 M
CASI TTM operating income is -$31.62 million

TTM Net Income

-$30.94 M
CASI TTM net profit is -$30.94 million

TTM EPS

-$2.24
CASI TTM earnings per share is -$2.24

CASI Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-21.4%+13.4%-34.9%
3 y3 years+123.8%+13.4%-34.9%
5 y5 years-+13.4%-34.9%

CASI Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-21.4%+12.3%-48.9%+128.6%-49.5%at low
5 y5-year-21.4%+720.1%-48.9%+479.8%-49.5%+433.9%
alltimeall time-21.4%>+9999.0%-48.9%>+9999.0%-49.5%>+9999.0%

CASI Pharmaceuticals Revenue History

DateAnnualQuarterlyTTM
Sep 2024
-
$7.79 M(+95.9%)
$22.05 M(-4.5%)
Jun 2024
-
$3.98 M(+16.7%)
$23.10 M(-20.2%)
Mar 2024
-
$3.41 M(-50.4%)
$28.94 M(-14.6%)
Dec 2023
$33.88 M(-21.4%)
$6.87 M(-22.2%)
$33.88 M(-19.8%)
Sep 2023
-
$8.84 M(-10.0%)
$42.26 M(-3.2%)
Jun 2023
-
$9.82 M(+17.6%)
$43.64 M(+2.9%)
Mar 2023
-
$8.35 M(-45.3%)
$42.39 M(-1.7%)
Dec 2022
$43.11 M(+42.9%)
$15.26 M(+49.4%)
$43.11 M(+16.5%)
Sep 2022
-
$10.21 M(+19.1%)
$37.01 M(+6.0%)
Jun 2022
-
$8.57 M(-5.4%)
$34.91 M(+4.2%)
Mar 2022
-
$9.06 M(-1.0%)
$33.49 M(+11.0%)
Dec 2021
$30.17 M(+99.2%)
$9.16 M(+12.9%)
$30.17 M(+16.8%)
Sep 2021
-
$8.11 M(+13.3%)
$25.83 M(+17.6%)
Jun 2021
-
$7.16 M(+24.9%)
$21.96 M(+25.7%)
Mar 2021
-
$5.74 M(+19.0%)
$17.47 M(+15.4%)
Dec 2020
$15.14 M(+266.5%)
$4.82 M(+13.7%)
$15.14 M(+29.8%)
Sep 2020
-
$4.24 M(+58.8%)
$11.66 M(+14.3%)
Jun 2020
-
$2.67 M(-21.6%)
$10.21 M(+35.4%)
Mar 2020
-
$3.41 M(+153.4%)
$7.54 M(+82.4%)
Dec 2019
$4.13 M(+8560.4%)
$1.34 M(-51.8%)
$4.13 M(+48.2%)
Sep 2019
-
$2.79 M(>+9900.0%)
$2.79 M(+3803.4%)
Dec 2015
$47.70 K(+101.3%)
-
-
Jun 2015
-
$24.00 K(+1.3%)
$71.40 K(+50.6%)
Mar 2015
-
$23.70 K(0.0%)
$47.40 K(+100.0%)
Dec 2014
$23.70 K(-96.5%)
$23.70 K(-96.5%)
$23.70 K(-96.5%)
Dec 2012
$669.30 K(-65.5%)
$669.30 K(-65.4%)
$669.30 K(-65.5%)
Dec 2011
$1.94 M(-47.4%)
$1.93 M(>+9900.0%)
$1.94 M(-47.6%)
Jun 2011
-
$8900.00(-99.8%)
$3.70 M(+0.2%)
Dec 2010
$3.69 M(-30.1%)
$3.69 M(+128.6%)
$3.69 M(-30.1%)
Dec 2009
$5.28 M(-29.3%)
$1.62 M(-56.0%)
$5.28 M(-30.9%)
Sep 2009
-
$3.67 M(-7.7%)
$7.64 M(+2.2%)
Dec 2008
$7.48 M(+1.1%)
$3.98 M(+13.6%)
$7.48 M(+1.4%)
Sep 2008
-
$3.50 M(-9.7%)
$7.38 M(-0.3%)
Dec 2007
$7.40 M(+7.3%)
$3.88 M(+10.1%)
$7.40 M(+0.1%)
Sep 2007
-
$3.52 M(-9.1%)
$7.39 M(+7.2%)
Dec 2006
$6.89 M(+16.5%)
$3.87 M(+28.0%)
$6.89 M(-2.7%)
Sep 2006
-
$3.02 M(-25.6%)
$7.09 M(+19.8%)
Dec 2005
$5.92 M
$4.06 M(+225.2%)
$5.92 M(+197.7%)
DateAnnualQuarterlyTTM
Sep 2005
-
$1.25 M(+115.6%)
$1.99 M(+125.6%)
Jun 2005
-
$579.50 K(+2199.6%)
$881.30 K(+99.8%)
Mar 2005
-
$25.20 K(-81.2%)
$441.20 K(-14.2%)
Dec 2004
$514.00 K(-67.4%)
$133.90 K(-6.2%)
$514.00 K(-42.7%)
Sep 2004
-
$142.70 K(+2.4%)
$897.60 K(-11.4%)
Jun 2004
-
$139.40 K(+42.2%)
$1.01 M(-12.6%)
Mar 2004
-
$98.00 K(-81.1%)
$1.16 M(-26.4%)
Dec 2003
$1.58 M(+33.9%)
$517.50 K(+100.2%)
$1.58 M(+3.7%)
Sep 2003
-
$258.50 K(-9.6%)
$1.52 M(-5.4%)
Jun 2003
-
$286.00 K(-44.3%)
$1.61 M(-1.4%)
Mar 2003
-
$513.50 K(+11.2%)
$1.63 M(+38.6%)
Dec 2002
$1.18 M(-36.8%)
$461.80 K(+33.6%)
$1.18 M(+39.4%)
Sep 2002
-
$345.60 K(+11.8%)
$844.20 K(+43.2%)
Jun 2002
-
$309.20 K(+416.2%)
$589.60 K(-43.2%)
Mar 2002
-
$59.90 K(-53.7%)
$1.04 M(-44.3%)
Dec 2001
$1.86 M(-49.3%)
$129.50 K(+42.3%)
$1.86 M(-37.0%)
Sep 2001
-
$91.00 K(-88.0%)
$2.96 M(-20.5%)
Jun 2001
-
$757.50 K(-14.3%)
$3.72 M(-2.9%)
Mar 2001
-
$884.00 K(-27.8%)
$3.83 M(+4.3%)
Dec 2000
$3.67 M(-26.8%)
$1.22 M(+43.3%)
$3.67 M(+28.1%)
Sep 2000
-
$854.20 K(-1.5%)
$2.87 M(-24.8%)
Jun 2000
-
$866.90 K(+19.3%)
$3.81 M(-10.8%)
Mar 2000
-
$726.70 K(+74.0%)
$4.27 M(-14.4%)
Dec 1999
$5.02 M(-3.5%)
$417.60 K(-76.8%)
$4.99 M(-17.8%)
Sep 1999
-
$1.80 M(+35.4%)
$6.07 M(+9.0%)
Jun 1999
-
$1.33 M(-8.0%)
$5.57 M(+2.4%)
Mar 1999
-
$1.44 M(-3.7%)
$5.44 M(+4.7%)
Dec 1998
$5.20 M(+8.3%)
$1.50 M(+15.4%)
$5.20 M(+2.0%)
Sep 1998
-
$1.30 M(+8.3%)
$5.10 M(+2.0%)
Jun 1998
-
$1.20 M(0.0%)
$5.00 M(+2.0%)
Mar 1998
-
$1.20 M(-14.3%)
$4.90 M(+2.1%)
Dec 1997
$4.80 M(+4.3%)
$1.40 M(+16.7%)
$4.80 M(+2.1%)
Sep 1997
-
$1.20 M(+9.1%)
$4.70 M(+2.2%)
Jun 1997
-
$1.10 M(0.0%)
$4.60 M(0.0%)
Mar 1997
-
$1.10 M(-15.4%)
$4.60 M(0.0%)
Dec 1996
$4.60 M
$1.30 M(+18.2%)
$4.60 M(+39.4%)
Sep 1996
-
$1.10 M(0.0%)
$3.30 M(+50.0%)
Jun 1996
-
$1.10 M(0.0%)
$2.20 M(+100.0%)
Mar 1996
-
$1.10 M
$1.10 M

FAQ

  • What is CASI Pharmaceuticals annual revenue?
  • What is the all time high annual revenue for CASI Pharmaceuticals?
  • What is CASI Pharmaceuticals annual revenue year-on-year change?
  • What is CASI Pharmaceuticals quarterly revenue?
  • What is the all time high quarterly revenue for CASI Pharmaceuticals?
  • What is CASI Pharmaceuticals quarterly revenue year-on-year change?
  • What is CASI Pharmaceuticals TTM revenue?
  • What is the all time high TTM revenue for CASI Pharmaceuticals?
  • What is CASI Pharmaceuticals TTM revenue year-on-year change?

What is CASI Pharmaceuticals annual revenue?

The current annual revenue of CASI is $33.88 M

What is the all time high annual revenue for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high annual revenue is $43.11 M

What is CASI Pharmaceuticals annual revenue year-on-year change?

Over the past year, CASI annual revenue has changed by -$9.23 M (-21.41%)

What is CASI Pharmaceuticals quarterly revenue?

The current quarterly revenue of CASI is $7.79 M

What is the all time high quarterly revenue for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high quarterly revenue is $15.26 M

What is CASI Pharmaceuticals quarterly revenue year-on-year change?

Over the past year, CASI quarterly revenue has changed by +$919.00 K (+13.37%)

What is CASI Pharmaceuticals TTM revenue?

The current TTM revenue of CASI is $22.05 M

What is the all time high TTM revenue for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high TTM revenue is $43.64 M

What is CASI Pharmaceuticals TTM revenue year-on-year change?

Over the past year, CASI TTM revenue has changed by -$11.82 M (-34.90%)